Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 56 Results

Title
Intervention Indication Therapeutic Area Year Actions
ABBV-951 for motor fluctuations in Parkinson’s disease ABBV-951 (fixed dose combination: Carbidopa; Levodopa) Parkinson's disease Neurology 2020 View  |  Download
Aducanumab for mild cognitive impairment due to Alzheimer’s disease Aducanumab (BIIB037) Cognitive impairment Neurology 2020 View  |  Download
Arimoclomol for Niemann-Pick Disease type C - add-on therapy Arimoclomol (BRX-345) Niemann-Pick Disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders , Neurology 2017 View  |  Download
Atogepant for prevention of migraine Atogepant (AGN-241689; MK-8031) Migraine Neurology 2022 View  |  Download
BIIB092 for progressive supranuclear palsy Gosuranemab (BIIB092; BMS-986168; IPN007) Progressive supranuclear palsy (PSP) Neurology 2019 View  |  Download
Biotin for Adrenomyeloneuropathy without cerebral involvement Biotin (MD1003; Qizenday; Vitamin B7) Adrenomyeloneuropathy (AMN) Genetic Disorders , Neurology 2017 View  |  Download
Cannabidiol in a pharmaceutical formulation (Epidiolex; GWP42003-P) for Lennox-Gastaut syndrome in children and adults Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS) Lennox-Gastaut syndrome Neurology 2017 View  |  Download
Cenobamate as an adjunctive therapy for primary generalised tonic-clonic seizures Cenobamate (YKP3089) Primary generalised tonic-clonic seizures Neurology 2022 View  |  Download
Cenobamate for Partial Focal Epilepsy – Adjunctive Therapy Cenobamate (YKP3089) Epilepsy Neurology 2018 View  |  Download
Clostridium botulinum neurotoxin A (Xeomin) for lower limb spasticity due to cerebral palsy – first line Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Lower limb spasticity Musculoskeletal System , Neurology 2017 View  |  Download
1 2 3 5 6
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications